Suchergebnisse - "Amyloidosis"

PubPharm (13.137)

1

Chronic underlying gastrointestinal amyloidosis was revealed by cardiac echography : a case report from Syria

enthalten in: Annals of medicine and surgery (2012) | 2024

von Asaad, A. | Ranjous, Y. | Hassan, Z. | +3

2

Systemic Amyloid A Protein Amyloidosis With Gastrointestinal Involvement

enthalten in: ACG case reports journal | 2024

von Akharume, O. | Ojeniyi, S. | Naqvi, H.

3

When Waldenström macroglobulinemia hits the kidney : Description of a case series and management of a "rare in rare" scenario

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Danesin, N. | Scapinello, G. | Del Prete, D. | +15

4

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion : An Open-Label Phase 1b Study Evaluating the Safety and Efficacy of ABBV-383 in AL Amyloidosis

enthalten in: ClinicalTrials.gov | 2024

5

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM : A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Amyloid Depleter ALXN2220 in Adult Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

enthalten in: ClinicalTrials.gov | 2024

6

bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease

enthalten in: Annals of the rheumatic diseases | 2024

von Kvacskay, P. | Hegenbart, U. | Lorenz, H. | +2

7

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis : APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)

enthalten in: ClinicalTrials.gov | 2024

8

Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant : An Open-label Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of Patisiran-LNP in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) With Disease Progression Post-Orthotopic Liver Transplant

enthalten in: ClinicalTrials.gov | 2024

9

APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) : APOLLO-B: A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

enthalten in: ClinicalTrials.gov | 2024

10

Concomitant amyloidosis is the primary cause of endothelial and coronary microvascular dysfunction in carpal tunnel syndrome

enthalten in: American heart journal plus : cardiology research and practice | 2024

von İrgi, T. | Baycan, �. | Güvenç, T. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1314]